Exogenus Therapeutics
PrivateLast Round
Strategic
Apr 24, 2024
Total Funding Raised
$1.32M
Momentum Score
25 /100
Company Overview
Exogenus Therapeutics is a biotechnology company developing an exosome-based platform technology designed to offer a pipeline of therapeutic products for skin and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exogenus Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Exogenus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 24, 2024 | ||||
| Grant | Nov 9, 2022 | ||||
| Grant | Dec 30, 2019 | ||||
| Seed | Dec 10, 2015 | ||||
| Pre Seed | Aug 1, 2015 |
Exogenus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon 2020 | Grant |
| 3xP Global | Strategic |
| COHiTEC Program | Accelerator |
| Caixa Capital Risc | Pre Seed, Seed |
| Blue Bio Value | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 1680% from 15 to 267.
- Dec 5, 2024
Grew 40% QoQ from 10 to 14 employees.
Exogenus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exogenus Therapeutics's valuation, stock price, and market status.
